Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting.
about
Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptorProtein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancerThe Chlamydia pneumoniae invasin protein Pmp21 recruits the EGF receptor for host cell entryInhibition of cell proliferation by an anti-EGFR aptamerEpidermal growth factor receptor translocation to the mitochondria: regulation and effect.Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines.Nanoscale imaging of epidermal growth factor receptor clustering: effects of inhibitorsDynamic imaging of molecular assemblies in live cells based on nanoparticle plasmon resonance coupling.Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling.Photochemical internalization of tumor-targeted protein toxins.Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis.D-Amino acid peptide residualizing agents bearing N-hydroxysuccinimido- and maleimido-functional groups and their application for trastuzumab radioiodinationCetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain.Recent advances in biomarkers and potential targeted therapies in head and neck squamous cell carcinoma.Bispecific designed ankyrin repeat proteins (DARPins) targeting epidermal growth factor receptor inhibit A431 cell proliferation and receptor recyclingAnti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity.Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR.Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.(-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cellsEndocytic downregulation of ErbB receptors: mechanisms and relevance in cancerTargeting EGFR resistance networks in head and neck cancer.Targeting the EGF receptor ectodomain in the context of cancer.Targeting the epidermal growth factor receptor in solid tumor malignancies.Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks.Cetuximab treatment alters the content of extracellular vesicles released from tumor cells.Quantitative measurement of the target-mediated internalization kinetics of biopharmaceuticalsEnhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration.Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line.Cellular and molecular properties of (90)Y-labeled cetuximab in combination with radiotherapy on human tumor cells in vitro.Cetuximab insufficiently inhibits glioma cell growth due to persistent EGFR downstream signaling.Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys.Single particle tracking-based reaction progress kinetic analysis reveals a series of molecular mechanisms of cetuximab-induced EGFR processes in a single living cell.Ultraviolet irradiation can induce evasion of colon cancer cells from stimulation of epidermal growth factor.Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies.Emerging functions of the EGFR in cancer.89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors.Conserved effects and altered trafficking of Cetuximab antibodies conjugated to gold nanoparticles with precise control of their number and orientation.Responsive Contrast Agents: Synthesis and Characterization of a Tunable Series of pH-Sensitive Near-Infrared Pentamethines.
P2860
Q24314620-87E0BD05-5FF5-4B46-BB4F-1C17CF13ACEDQ26852215-13973FF2-4EDD-4398-BF5A-1E30AC269A90Q27334989-7F4F3AC8-5057-4138-AD2B-3A648817D167Q28743866-E2875884-3D41-4F36-BC40-41662F78BE2CQ30433793-8B5ADABB-CFFC-4478-BD84-EE2BDEA69A4AQ33358967-79B77DA3-BE69-48AA-9234-3D7024035CF4Q33661563-4D260719-DA80-411F-B4E2-90589E8297A8Q33775739-25716049-D0DC-4BC5-9B9F-B7CD94B1E906Q34067821-89286D81-0B2E-4F28-AF40-162A228B25ABQ34068201-B7D747AD-58A4-4AE8-BFB9-1B588F0E9151Q34093260-74F61079-3438-4566-B5DB-EB0236C6DD5DQ34718122-64ABA069-F48A-4C2B-8DAC-3C574BDB0DDDQ35654360-64EFDFA4-ED27-4EE9-BF11-3E3C04D17DB9Q35803276-808EDA08-CAF9-49B5-9BFA-01BD414A8503Q35825299-9D8C36B1-D102-4E22-BACE-F013F9967CB5Q35842099-1051DFDA-818A-43C5-ABE9-D66874F0E48EQ36296101-AF90A34B-C721-4E8E-ADE1-DC83503DEACDQ36583011-0F7BB6C7-A0C7-4196-840C-C75C1A7AD493Q36797398-F73DAB32-400D-4E4C-919D-C4D9D67C84F7Q36916857-27CF7B36-5139-47EB-BC3C-04F9CBA15184Q37089778-80F4947E-181A-4C3B-9675-877D46E3DFEAQ37405633-50B1E825-665D-4DB6-B61A-47EC7BC55B00Q37600910-65630205-135E-44D5-A4B1-93B0C84A56BDQ37990044-40F4EA7A-4D4A-43FC-87A0-A82B7B728011Q38172182-731850D6-97A8-4950-A67F-729400893CBEQ38782738-39833333-C874-49C0-A149-04C60660C5F9Q38957698-6195363F-9FE8-4C22-9C4A-7378F7CD5FEEQ38998238-C1D08ED4-5317-49DE-ADDA-810E84B78500Q39229818-35125F19-FAF1-4279-A2D2-FBF6CB5848F0Q39300555-BDE2CBEF-6F05-425A-A179-60A4E458AF16Q39700144-2EC574D2-30D4-4D84-BB04-9FBFE1122098Q40545249-E4D29F62-3C95-4624-9F1E-E27031C56052Q41671180-4464E6AF-0142-4B8D-B174-F8110BA610C4Q42115280-971E7BA2-668D-44E5-8B19-0CF4BE3F7B9AQ46523280-788B0F66-81BB-4DAF-9269-D2804D153064Q47124344-266FFC7E-5744-43CE-98ED-E253FB655421Q48184539-A302C36D-ABC1-4D17-9550-FC63623473A8Q50697137-9414461A-8897-42B4-BCCD-64C32B042D44Q55664571-05F668EE-8D89-4095-9BF1-47893872AC69
P2860
Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Effect of the anti-receptor li ...... eptor endocytosis and sorting.
@en
type
label
Effect of the anti-receptor li ...... eptor endocytosis and sorting.
@en
prefLabel
Effect of the anti-receptor li ...... eptor endocytosis and sorting.
@en
P2093
P1476
Effect of the anti-receptor li ...... eptor endocytosis and sorting.
@en
P2093
Abedelnasser Abulrob
Beatrice Paul-Roc
Maria L Jaramillo
Maureen O'Connor McCourt
Suzanne Grothe
Zully Leon
P304
P356
10.1016/J.YEXCR.2006.05.008
P407
P577
2006-05-23T00:00:00Z